{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:38:13Z","timestamp":1784299093135,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Clinically significant pericardial effusions and cardiac tamponade in systemic sclerosis (SSc) patients is uncommon and the factors that contribute to progression of pericardial involvement in SSc patients have not been well established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A review of the national inpatient sample database was performed looking SSc related hospitalizations between 2002 and 2019. Data was collected on patients with pericardial effusions and cardiac tamponade and analyzed to identify and describe patient characteristics and comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of a total of 523,410 SSc hospitalizations, with an overall inpatient mortality rate of 4.7% (24,764 patients), pericardial effusion was identified in 3.1% of all hospitalizations (16,141 patients) out of which 0.2% (838 patients) had a diagnosis of cardiac tamponade. Patients with pericardial effusion were significantly more likely to have pulmonary circulatory disease (p\u2009=\u2009&lt;\u20090.0001), congestive heart failure (p\u2009=\u2009&lt;\u20090.0001) end stage renal disease (p\u2009=\u2009&lt;\u20090.0001), diabetes (p\u2009=\u20090.015), and hypothyroidism (p\u2009=\u20090.025). Patients with cardiac tamponade were significantly more likely to have a history of coronary artery bypass graft surgery (p\u2009=\u20090.001) or atrial fibrillation (p\u2009=\u2009&lt;\u20090.0001). Hospitalized patients with cardiac tamponade had a significantly increased mortality rate of 17.7% compared to 8.8% in patients with pericardial effusions without a tamponade physiology, with an odds ratio of 2.3 (1.97\u20132.86), p\u2009=\u2009&lt;\u20090.0001.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pericardial effusion and tamponade are associated with increased morbidity and mortality in SSc patients. Further studies are required to explore the role of patient comorbidities and characteristics in development into pericardial effusions or tamponade.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-023-00360-9","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:34:26Z","timestamp":1695857666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pericardial effusions and cardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample"],"prefix":"10.1186","volume":"7","author":[{"given":"Bikash","family":"Basyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris T.","family":"Derk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/rheumatology\/kem273","volume":"46","author":"L Chung","year":"2007","unstructured":"Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. Rheumatology. 2007;46:1808\u201313.","journal-title":"Rheumatology"},{"key":"360_CR2","first-page":"2031","volume":"28","author":"PJ Nietert","year":"2001","unstructured":"Nietert PJ, Silverstein MD, Silver RM. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rhuematol. 2001;28:2031\u20137.","journal-title":"J Rhuematol"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/rheumatology\/key150","volume":"57","author":"D Ram Poudel","year":"2018","unstructured":"Ram Poudel D, George M, Dhital R, Karmacharya P, Sandorfi N, Derk CT. Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample. Rheumatology. 2018;57:1611\u201322.","journal-title":"Rheumatology"},{"key":"360_CR4","doi-asserted-by":"publisher","first-page":"iii45","DOI":"10.1093\/rheumatology\/kep110","volume":"48","author":"A Kahan","year":"2009","unstructured":"Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology. 2009;48:iii45\u20138.","journal-title":"Rheumatology"},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3899\/jrheum.180018","volume":"46","author":"VM Hsu","year":"2019","unstructured":"Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD. Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the PHAROS Registry. J Rhuematol. 2019;46:176\u201383.","journal-title":"J Rhuematol"},{"key":"360_CR6","doi-asserted-by":"crossref","unstructured":"Hosoya H, Derk CT. Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management. BioMed Research International 2018; 2018: 6812082.","DOI":"10.1155\/2018\/6812082"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/1756-185X.12952","volume":"20","author":"A Fern\u00e1ndez Morales","year":"2017","unstructured":"Fern\u00e1ndez Morales A, Iniesta N, Fern\u00e1ndez-Codina A, Vaz de Cunha J, P\u00e9rez Romero T, Hurtado Garc\u00eda R, Sime\u00f3n-Aznar CP, Fonollosa V, Cervera R, Espinosa G. Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature. Int J Rheum Dis. 2017;20:1582\u201392.","journal-title":"Int J Rheum Dis"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00296-015-3382-2","volume":"37","author":"A Fern\u00e1ndez-Codina","year":"2017","unstructured":"Fern\u00e1ndez-Codina A, Sime\u00f3n-Aznar CP, Pinal-Fernandez I, Rodr\u00edguez-Palomares J, Pizzi MN, Hidalgo CE, Del Castillo AG, Prado-Galbarro FJ, Sarria-Santamera A. Fonollosa-Pl\u00e0 V and Vilardell-Tarr\u00e9s M. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017;37:75\u201384.","journal-title":"Rheumatol Int"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/ard.56.6.393","volume":"56","author":"RJ Byers","year":"1997","unstructured":"Byers RJ, Marshall DAS, Freemont AJ. Pericardial involvement in systemic sclerosis. Ann Rheum Dis. 1997;56:393\u20134.","journal-title":"Ann Rheum Dis"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/heartjnl-2011-300054","volume":"97","author":"M Imazio","year":"2011","unstructured":"Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97:1882\u201392.","journal-title":"Heart"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/qjmed\/hcx195","volume":"111","author":"RP Goswami","year":"2017","unstructured":"Goswami RP, Sircar G, Ghosh A, Ghosh P. Cardiac tamponade in systemic lupus erythematosus. QJM: An International Journal of Medicine. 2017;111:83\u20137.","journal-title":"QJM: An International Journal of Medicine"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/0002-9343(74)90008-4","volume":"57","author":"JE McWhorter","year":"1974","unstructured":"McWhorter JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med. 1974;57:566\u201375.","journal-title":"Am J Med"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.12998\/wjcc.v9.i14.3252","volume":"9","author":"MZ Khan","year":"2021","unstructured":"Khan MZ, Patel K, Patel KA, Doshi R, Shah V, Adalja D, Waqar Z, Franklin S, Gupta N, Gul MH, Jesani S, Kutalek S, Figueredo V. Burden of atrial fibrillation in patients with rheumatic diseases. World J Clin Cases. 2021;9:3252\u201364.","journal-title":"World J Clin Cases"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-023-00360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-023-00360-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-023-00360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:31:37Z","timestamp":1700526697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-023-00360-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1186\/s41927-023-00360-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3102421\/v1","asserted-by":"object"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"24 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research using the National Inpatient Sample (NIS) does not require Institutional Review Board review or an exempt determination according to the National Bureau of economic research (NBER).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}